REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/02/2026
Back to search
Official data from USPTO
GENEFINDER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
02/03/2026
Trademark type
Combined
Nice classes
5
Filing date
06/12/2020
Registration date
02/02/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/02/2021
Last transaction
02/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2013-00-00
First use in commerce
03/16/2020
Drawing code
3
Owner type
03
Owner location
Gyeonggi-do, KR
Examiner
HARDY LUDLOW, TARAH KIM
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
THE MARK CONSISTS OF THE WORD "GENEFINDER" AND A DESIGN IS TO THE LEFT OF THE WORDING CONSISTING OF TWO RIBBON-LIKE LINES THAT MIRROR ONE ANOTHER AND CURVE INWARD AND OUTWARD JOINING AT TWO POINTS.
Holders and representatives
Holders
OSANG HEALTHCARE CO., LTD.
Representatives
John Alumit ALUMIT IP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic agentspreparationssubstances for medical purposes; diagnostic reagents for medical purposes; diagnostic test kit for medical purposes comprised of primersprobesbuffers and reagents for use in disease testing; medical diagnostic kit comprised of primersprobesbuffers and reagents for the detection of infectious disease; medical diagnostic reagents for diagnosing genetic diseases; medical diagnostic test kit comprised of primersprobesbuffers and reagents for diagnosing genetic diseases; medical diagnostic reagents for cancer diagnosis; medical diagnostic test kit comprised of primersprobesbuffers and reagents for cancer diagnosis; diagnostic preparations for medical or veterinary purposes; chemical reagents for medical research and medical purposes; medical diagnostic reagents for pharmaceutical purpose; diagnostic reagents for medical laboratory or clinical purposes
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/02/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/17/2020
PUBO
PUBLISHED FOR OPPOSITION
11/17/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/28/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/14/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/13/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/12/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/12/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/23/2020
GNRT
NON-FINAL ACTION E-MAILED
09/23/2020
CNRT
NON-FINAL ACTION WRITTEN
09/23/2020
DOCK
ASSIGNED TO EXAMINER
09/16/2020
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/11/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/10/2020
NWAP
NEW APPLICATION ENTERED
06/16/2020
Continuous trademark protection
Get notified about every new filing that threatens GENEFINDER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.